請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46696
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張明富 | |
dc.contributor.author | Pei-Ju Chen | en |
dc.contributor.author | 陳姵儒 | zh_TW |
dc.date.accessioned | 2021-06-15T05:23:52Z | - |
dc.date.available | 2013-09-09 | |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-07-19 | |
dc.identifier.citation | 1. Rizzetto, M., Canese, M. G., Gerin, J. L., London, W. T., Sly, D. L., and Purcell, R. H. (1980) Transmission of the hepatitis B virus-associated delta antigen to chimpanzees, J Infect Dis 141, 590-602.
2. Shepard, C. W., Finelli, L., and Alter, M. J. (2005) Global epidemiology of hepatitis C virus infection, Lancet Infect Dis 5, 558-567. 3. Plagemann, P. G. (1991) Hepatitis C virus, Arch Virol 120, 165-180. 4. Honda, M., Ping, L. H., Rijnbrand, R. C., Amphlett, E., Clarke, B., Rowlands, D., and Lemon, S. M. (1996) Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA, Virology 222, 31-42. 5. Di Bisceglie, A. M., Order, S. E., Klein, J. L., Waggoner, J. G., Sjogren, M. H., Kuo, G., Houghton, M., Choo, Q. L., and Hoofnagle, J. H. (1991) The role of chronic viral hepatitis in hepatocellular carcinoma in the United States, Am J Gastroenterol 86, 335-338. 6. Lai, M. Y., Kao, J. H., Yang, P. M., Wang, J. T., Chen, P. J., Chan, K. W., Chu, J. S., and Chen, D. S. (1996) Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C, Gastroenterology 111, 1307-1312. 7. Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P. J., and et al. (1991) Genetic organization and diversity of the hepatitis C virus, Proc Natl Acad Sci U S A 88, 2451-2455. 8. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T., and Shimotohno, K. (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis, Proc Natl Acad Sci U S A 87, 9524-9528. 9. Holland, J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S., and VandePol, S. (1982) Rapid evolution of RNA genomes, Science 215, 1577-1585. 10. Martell, M., Esteban, J. I., Quer, J., Genesca, J., Weiner, A., Esteban, R., Guardia, J., and Gomez, J. (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution, J Virol 66, 3225-3229. 11. Ogata, N., Alter, H. J., Miller, R. H., and Purcell, R. H. (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus, Proc Natl Acad Sci U S A 88, 3392-3396. 12. Weiner, A. J., Brauer, M. J., Rosenblatt, J., Richman, K. H., Tung, J., Crawford, K., Bonino, F., Saracco, G., Choo, Q. L., Houghton, M., and et al. (1991) Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins, Virology 180, 842-848. 13. Bukh, J., Purcell, R. H., and Miller, R. H. (1992) Sequence analysis of the 5' noncoding region of hepatitis C virus, Proc Natl Acad Sci U S A 89, 4942-4946. 14. Cha, T. A., Beall, E., Irvine, B., Kolberg, J., Chien, D., Kuo, G., and Urdea, M. S. (1992) At least five related, but distinct, hepatitis C viral genotypes exist, Proc Natl Acad Sci U S A 89, 7144-7148. 15. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S. W., Chayama, K., Chen, D. S., and et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes, Hepatology 19, 1321-1324. 16. van Doorn, L. J., Capriles, I., Maertens, G., DeLeys, R., Murray, K., Kos, T., Schellekens, H., and Quint, W. (1995) Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses, J Virol 69, 773-778. 17. Chen, P. J., Lin, M. H., Tai, K. F., Liu, P. C., Lin, C. J., and Chen, D. S. (1992) The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA, Virology 188, 102-113. 18. Sy, T., and Jamal, M. M. (2006) Epidemiology of hepatitis C virus (HCV) infection, Int J Med Sci 3, 41-46. 19. Wasley, A., and Alter, M. J. (2000) Epidemiology of hepatitis C: geographic differences and temporal trends, Semin Liver Dis 20, 1-16. 20. Gumber, S. C., and Chopra, S. (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations, Ann Intern Med 123, 615-620. 21. Lonardo, A., Adinolfi, L. E., Loria, P., Carulli, N., Ruggiero, G., and Day, C. P. (2004) Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease, Gastroenterology 126, 586-597. 22. Chen, H. F., Li, C. Y., Chen, P., See, T. T., and Lee, H. Y. (2006) Seroprevalence of hepatitis B and C in type 2 diabetic patients, J Chin Med Assoc 69, 146-152. 23. Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., and Thomas, D. L. (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States, Ann Intern Med 133, 592-599. 24. Kaito, M., Watanabe, S., Tsukiyama-Kohara, K., Yamaguchi, K., Kobayashi, Y., Konishi, M., Yokoi, M., Ishida, S., Suzuki, S., and Kohara, M. (1994) Hepatitis C virus particle detected by immunoelectron microscopic study, J Gen Virol 75 ( Pt 7), 1755-1760. 25. Takahashi, K., Kishimoto, S., Yoshizawa, H., Okamoto, H., Yoshikawa, A., and Mishiro, S. (1992) p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts, Virology 191, 431-434. 26. Takamizawa, A., Mori, C., Fuke, I., Manabe, S., Murakami, S., Fujita, J., Onishi, E., Andoh, T., Yoshida, I., and Okayama, H. (1991) Structure and organization of the hepatitis C virus genome isolated from human carriers, J Virol 65, 1105-1113. 27. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., and Shimotohno, K. (1991) Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis, Proc Natl Acad Sci U S A 88, 5547-5551. 28. Lin, C., and Rice, C. M. (1995) The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay, Proc Natl Acad Sci U S A 92, 7622-7626. 29. Mizushima, H., Hijikata, M., Tanji, Y., Kimura, K., and Shimotohno, K. (1994) Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2, J Virol 68, 2731-2734. 30. Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N., Tanaka, T., Kimura, K., and Shimotohno, K. (1993) Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus, J Virol 67, 4665-4675. 31. Manabe, S., Fuke, I., Tanishita, O., Kaji, C., Gomi, Y., Yoshida, S., Mori, C., Takamizawa, A., Yosida, I., and Okayama, H. (1994) Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3, Virology 198, 636-644. 32. Tsukiyama-Kohara, K., Iizuka, N., Kohara, M., and Nomoto, A. (1992) Internal ribosome entry site within hepatitis C virus RNA, J Virol 66, 1476-1483. 33. Han, J. H., Shyamala, V., Richman, K. H., Brauer, M. J., Irvine, B., Urdea, M. S., Tekamp-Olson, P., Kuo, G., Choo, Q. L., and Houghton, M. (1991) Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end, Proc Natl Acad Sci U S A 88, 1711-1715. 34. Brown, E. A., Zhang, H., Ping, L. H., and Lemon, S. M. (1992) Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs, Nucleic Acids Res 20, 5041-5045. 35. Honda, M., Beard, M. R., Ping, L. H., and Lemon, S. M. (1999) A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation, J Virol 73, 1165-1174. 36. Tanaka, T., Kato, N., Cho, M. J., and Shimotohno, K. (1995) A novel sequence found at the 3' terminus of hepatitis C virus genome, Biochem Biophys Res Commun 215, 744-749. 37. Santolini, E., Migliaccio, G., and La Monica, N. (1994) Biosynthesis and biochemical properties of the hepatitis C virus core protein, J Virol 68, 3631-3641. 38. Ishida, S., Kaito, M., Kohara, M., Tsukiyama-Kohora, K., Fujita, N., Ikoma, J., Adachi, Y., and Watanabe, S. (2001) Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique, Hepatol Res 20, 335-347. 39. Bukh, J., Purcell, R. H., and Miller, R. H. (1994) Sequence analysis of the core gene of 14 hepatitis C virus genotypes, Proc Natl Acad Sci U S A 91, 8239-8243. 40. Chang, S. C., Yen, J. H., Kang, H. Y., Jang, M. H., and Chang, M. F. (1994) Nuclear localization signals in the core protein of hepatitis C virus, Biochem Biophys Res Commun 205, 1284-1290. 41. Ravaggi, A., Natoli, G., Primi, D., Albertini, A., Levrero, M., and Cariani, E. (1994) Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells, J Hepatol 20, 833-836. 42. Liu, Q., Tackney, C., Bhat, R. A., Prince, A. M., and Zhang, P. (1997) Regulated processing of hepatitis C virus core protein is linked to subcellular localization, J Virol 71, 657-662. 43. Ray, R. B., Lagging, L. M., Meyer, K., and Ray, R. (1996) Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype, J Virol 70, 4438-4443. 44. Ray, R. B., Meyer, K., and Ray, R. (1996) Suppression of apoptotic cell death by hepatitis C virus core protein, Virology 226, 176-182. 45. Chen, C. M., You, L. R., Hwang, L. H., and Lee, Y. H. (1997) Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor, J Virol 71, 9417-9426. 46. Ruggieri, A., Harada, T., Matsuura, Y., and Miyamura, T. (1997) Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein, Virology 229, 68-76. 47. Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., and Lai, M. M. (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis, J Virol 72, 3691-3697. 48. Matsumoto, M., Hsieh, T. Y., Zhu, N., VanArsdale, T., Hwang, S. B., Jeng, K. S., Gorbalenya, A. E., Lo, S. Y., Ou, J. H., Ware, C. F., and Lai, M. M. (1997) Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor, J Virol 71, 1301-1309. 49. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice, Nat Med 4, 1065-1067. 50. Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Ishibashi, K., Matsuura, Y., Miyamura, T., and Koike, K. (1997) Hepatitis C virus core protein induces hepatic steatosis in transgenic mice, J Gen Virol 78 ( Pt 7), 1527-1531. 51. Spaete, R. R., Alexander, D., Rugroden, M. E., Choo, Q. L., Berger, K., Crawford, K., Kuo, C., Leng, S., Lee, C., Ralston, R., and et al. (1992) Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells, Virology 188, 819-830. 52. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., and Shimotohno, K. (1991) Hypervariable regions in the putative glycoprotein of hepatitis C virus, Biochem Biophys Res Commun 175, 220-228. 53. Grakoui, A., McCourt, D. W., Wychowski, C., Feinstone, S. M., and Rice, C. M. (1993) Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites, J Virol 67, 2832-2843. 54. Grakoui, A., McCourt, D. W., Wychowski, C., Feinstone, S. M., and Rice, C. M. (1993) A second hepatitis C virus-encoded proteinase, Proc Natl Acad Sci U S A 90, 10583-10587. 55. Hijikata, M., Mizushima, H., Tanji, Y., Komoda, Y., Hirowatari, Y., Akagi, T., Kato, N., Kimura, K., and Shimotohno, K. (1993) Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus, Proc Natl Acad Sci U S A 90, 10773-10777. 56. Eckart, M. R., Selby, M., Masiarz, F., Lee, C., Berger, K., Crawford, K., Kuo, C., Kuo, G., Houghton, M., and Choo, Q. L. (1993) The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor, Biochem Biophys Res Commun 192, 399-406. 57. Tai, C. L., Chi, W. K., Chen, D. S., and Hwang, L. H. (1996) The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3), J Virol 70, 8477-8484. 58. Failla, C., Tomei, L., and De Francesco, R. (1995) An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A, J Virol 69, 1769-1777. 59. Bartenschlager, R., Ahlborn-Laake, L., Mous, J., and Jacobsen, H. (1994) Kinetic and structural analyses of hepatitis C virus polyprotein processing, J Virol 68, 5045-5055. 60. Failla, C., Tomei, L., and De Francesco, R. (1994) Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins, J Virol 68, 3753-3760. 61. Kato, N., Yoshida, H., Ono-Nita, S. K., Kato, J., Goto, T., Otsuka, M., Lan, K., Matsushima, K., Shiratori, Y., and Omata, M. (2000) Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer, Hepatology 32, 405-412. 62. Park, J. S., Yang, J. M., and Min, M. K. (2000) Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene, Biochem Biophys Res Commun 267, 581-587. 63. Hirota, M., Satoh, S., Asabe, S., Kohara, M., Tsukiyama-Kohara, K., Kato, N., Hijikata, M., and Shimotohno, K. (1999) Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation, Virology 257, 130-137. 64. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kimura, K., and Shimotohno, K. (1994) Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome, Biochem Biophys Res Commun 205, 320-326. 65. Tanji, Y., Kaneko, T., Satoh, S., and Shimotohno, K. (1995) Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A, J Virol 69, 3980-3986. 66. Tu, H., Gao, L., Shi, S. T., Taylor, D. R., Yang, T., Mircheff, A. K., Wen, Y., Gorbalenya, A. E., Hwang, S. B., and Lai, M. M. (1999) Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein, Virology 263, 30-41. 67. Behrens, S. E., Tomei, L., and De Francesco, R. (1996) Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus, EMBO J 15, 12-22. 68. Lohmann, V., Korner, F., Herian, U., and Bartenschlager, R. (1997) Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity, J Virol 71, 8416-8428. 69. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., and Sato, C. (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection, N Engl J Med 334, 77-81. 70. Gale, M., Jr., Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R., and Katze, M. G. (1998) Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation, Mol Cell Biol 18, 5208-5218. 71. Arima, N., Kao, C. Y., Licht, T., Padmanabhan, R., and Sasaguri, Y. (2001) Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A, J Biol Chem 276, 12675-12684. 72. Baek, K. H., Park, H. Y., Kang, C. M., Kim, S. J., Jeong, S. J., Hong, E. K., Park, J. W., Sung, Y. C., Suzuki, T., Kim, C. M., and Lee, C. W. (2006) Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation, J Mol Biol 359, 22-34. 73. Ghosh, A. K., Steele, R., Meyer, K., Ray, R., and Ray, R. B. (1999) Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth, J Gen Virol 80 ( Pt 5), 1179-1183. 74. Ghosh, A. K., Majumder, M., Steele, R., Meyer, K., Ray, R., and Ray, R. B. (2000) Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death, Virus Res 67, 173-178. 75. Majumder, M., Ghosh, A. K., Steele, R., Ray, R., and Ray, R. B. (2001) Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner, J Virol 75, 1401-1407. 76. Cuenda, A., and Rousseau, S. (2007) p38 MAP-kinases pathway regulation, function and role in human diseases, Biochim Biophys Acta 1773, 1358-1375. 77. Lai, C. F., Chaudhary, L., Fausto, A., Halstead, L. R., Ory, D. S., Avioli, L. V., and Cheng, S. L. (2001) Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells, J Biol Chem 276, 14443-14450. 78. Rennefahrt, U., Illert, B., Greiner, A., Rapp, U. R., and Troppmair, J. (2004) Tumor induction by activated JNK occurs through deregulation of cellular growth, Cancer Lett 215, 113-124. 79. He, Y., Tan, S. L., Tareen, S. U., Vijaysri, S., Langland, J. O., Jacobs, B. L., and Katze, M. G. (2001) Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A, J Virol 75, 5090-5098. 80. Wu, S. C., Chang, S. C., Wu, H. Y., Liao, P. J., and Chang, M. F. (2008) Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway, J Biol Chem 283, 29396-29404. 81. He, Y., Nakao, H., Tan, S. L., Polyak, S. J., Neddermann, P., Vijaysri, S., Jacobs, B. L., and Katze, M. G. (2002) Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase, J Virol 76, 9207-9217. 82. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J., and Katze, M. G. (1999) NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling, Proc Natl Acad Sci U S A 96, 5533-5538. 83. Park, K. J., Choi, S. H., Choi, D. H., Park, J. M., Yie, S. W., Lee, S. Y., and Hwang, S. B. (2003) 1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2, J Biol Chem 278, 30711-30718. 84. Street, A., Macdonald, A., Crowder, K., and Harris, M. (2004) The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade, J Biol Chem 279, 12232-12241. 85. Choi, J., and Ou, J. H. (2006) Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus, Am J Physiol Gastrointest Liver Physiol 290, G847-851. 86. Surh, Y. J. (2003) Cancer chemoprevention with dietary phytochemicals, Nat Rev Cancer 3, 768-780. 87. Liebler, D. C., and Guengerich, F. P. (2005) Elucidating mechanisms of drug-induced toxicity, Nat Rev Drug Discov 4, 410-420. 88. Burdette, D., Olivarez, M., and Waris, G. (2010) Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway, J Gen Virol 91, 681-690. 89. Blank, V. (2008) Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?, J Mol Biol 376, 913-925. 90. Fujiwara, K. T., Kataoka, K., and Nishizawa, M. (1993) Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain, Oncogene 8, 2371-2380. 91. Amit, I., Citri, A., Shay, T., Lu, Y., Katz, M., Zhang, F., Tarcic, G., Siwak, D., Lahad, J., Jacob-Hirsch, J., Amariglio, N., Vaisman, N., Segal, E., Rechavi, G., Alon, U., Mills, G. B., Domany, E., and Yarden, Y. (2007) A module of negative feedback regulators defines growth factor signaling, Nat Genet 39, 503-512. 92. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D. R., Harada, T., Engel, J. D., and Yamamoto, M. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation, Nat Genet 35, 238-245. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46696 | - |
dc.description.abstract | C型肝炎病毒(hepatitis C virus)感染,常會演變成持續性感染並且可能引發肝癌。C型肝炎病毒非結構性蛋白質NS5A,目前已知會影響宿主細胞的生長和存活能力。本實驗室先前的研究顯示,NS5A蛋白質會與宿主細胞PKR (double-strand RNA-activated protein kinase)形成異源雙體並抑制PKR活性,使細胞通過細胞週期G2/M階段受到阻礙而延遲離開,造成染色體不穩定,可能為引發肝癌的原因之一。為了進一步釐清NS5A-PKR訊息傳遞路徑對於肝癌發生是否扮演重要角色,本論文首先於人類肝癌細胞株Huh7建立可穩定表現突變型NS5A蛋白質(NS5A-mPTT)的細胞株。在此Huh7系統中,突變型NS5A-mPTT蛋白質喪失與PKR形成異源雙體的能力,而NS5A蛋白質所造成的細胞週期異常調控及增殖速度變緩慢的現象,在突變型NS5A-mPTT蛋白質存在下則不會發生。使用軟瓊脂培養(soft agar)測試轉型(transformation)能力,結果發現穩定表現NS5A蛋白質的細胞相對於表現突變型NS5A-mPTT的細胞具有較高的轉型能力,顯示NS5A-PKR路徑對於肝癌發生扮演重要角色。過去研究顯示,NS5A蛋白質誘導活性氧化物(ROS)生成,造成DNA損傷(DNA damage),可能因此促使細胞走向癌化。而細胞內抗氧化防禦機制主要由Nrf2 (NF-E2-related factor-2)及small Maf (v-maf musculoaponeurotic fibrosarcoma oncogene family)異源雙體所調控。本論文在可穩定表現C型肝炎病毒1b strain之次基因體複製體細胞株(HCV subgenomic replicon)發現DNA損傷標記物8-hydroxyguanosine明顯增加。根據軟體分析發現small Maf家族成員中MafF啟動子上擁有可受NS5A蛋白質調控之轉錄因子的結合位置。利用反轉錄酶-即時聚合酶連鎖反應顯示,C型肝炎病毒1b strain之次基因體複製體,NS5A及突變型NS5A-mPTT細胞中,MafF基因表現量均下降。由MAPK及PI3K抑制劑的實驗結果推測,NS5A可能透過PKR-p38及ERK訊息傳遞路徑抑制MafF的基因表現,且此二路徑相互影響,此一立論進一步在螢光素酶分析(Luciferase reporter assay)得到了證實。相反的,在C型肝炎病毒1b strain之次基因體複製體細胞株發現Nrf2蛋白質的表現量及活性卻增加,可能是病毒調控細胞存活的作用機制之一。當細胞大量表現NS5A蛋白質時,再處理H2O2之後,確實會使細胞累積更大量DNA損傷。由本論文結果推測,NS5A蛋白質透過PKR-p38及EKR訊息傳遞路徑抑制MafF 基因表現而導致抗氧化防禦(antioxidant defense)能力降低,使DNA 受到傷害,可能是促使C型肝炎病毒感染細胞走向癌化的方式之一。 | zh_TW |
dc.description.abstract | Hepatitis C virus (HCV) often causes a persistent infection and virus-associated hepatocellular carcinoma. The viral nonstructural protein 5A (NS5A) is involved in the control of cell growth and viability. Results from our earlier studies indicated that NS5A can form heterodimer with PKR and down-regulate the PKR activity. Consequently, it causes cell cycle G2/M exit delay and leads to chromosome instability. The phenomenon provides insights into the molecular mechanisms of HCV-associated hepatocarcinogenesis. To clarify the importance of NS5A-PKR signaling pathway in HCV-associated hepatocarcinogenesis, Huh7 cells stably expressed the NS5A mutant, NS5A-mPTT, which has lost the ability of binding to PKR were generated in this study. NS5A de-regulated cell cycle and reduced the rate of cell proliferation, which were not observed in Huh7 cells constitutively expressing the NS5A-mPTT. Soft agar assay revealed a higher transformation ability of Huh7 cells constitutively expressing NS5A than those expressing NS5A-mPTT. This suggests a potential role of NS5A-PKR signaling pathway in the HCV-associated hepatocarcinogenesis. NS5A protein has been reported to induce reactive oxygen species (ROS) production that leads to DNA damage and possibly hepatocarcinogenesis. Heterodimer formation of Nrf2 (NF-E2-related factor-2) and small Maf (v-maf musculoaponeurotic fibrosarcoma oncogene family) is a major paradigm for the cellular antioxidant defense. In this study, the level of DNA damage marker 8-hydroxyguanosine signal was found to be significantly enhanced in Huh7 cells constitutively expressing the HCV subgenomic replicon of genotype 1b. Computer analysis revealed cis-elements of NS5A-regulated transcriptional factors on the promoter of MafF gene, a member of the small Maf family. RT-real-time PCR demonstrated down-regulation of MafF gene expression in Huh7 cells constitutively expressing the HCV subgenomic replicon of genotype 1b, the NS5A protein, or the NS5A-mPTT mutant protein. Luciferase reporter assay and RT-real-time PCR analysis carried out in the presence of MAPK, JNK or PI3K inhibitor further demonstrated that NS5A down-regulated MafF gene expression via the PKR-p38 and ERK signaling pathways. On the other hand, the expression level and activities of Nrf2 were up-regulated in the HCV subgenomic replicon cells, which may be involved in the cell viability. Furthermore, elevated DNA damage was detected in cells over-expressing NS5A upon H2O2 treatment. In conclusion, HCV NS5A protein down-regulates MafF gene expression via PKR-p38 and ERK signaling pathways, and attenuates the ability of antioxidant defense, leading to DNA damage. This could be one of the mechanisms involved in HCV-associated hepatocarcinogenesis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T05:23:52Z (GMT). No. of bitstreams: 1 ntu-99-R97442004-1.pdf: 2329008 bytes, checksum: c695698bef2fc895a50a52ca4ca80845 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員審定書I
致謝II 中文摘要IV 英文摘要VI 縮寫表IX 緒論1 本論文研究方向14 材料來源15 實驗方法21 結果35 討論43 圖表47 參考文獻69 | |
dc.language.iso | zh-TW | |
dc.title | C型肝炎病毒非結構性蛋白質NS5A透過MAPK訊息傳遞路徑調控抗氧化防禦相關基因 | zh_TW |
dc.title | Hepatitis C virus NS5A protein regulates the expression of antioxidant defense-associated genes through MAPK signaling pathway | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 許金玉,王萬波,李芳仁 | |
dc.subject.keyword | C型肝炎病毒,非結構性蛋白質5A,抗氧化,MafF,Nrf2,DNA 損傷, | zh_TW |
dc.subject.keyword | HCV,NS5A,antioxidant,MafF,Nrf2,DNA damage, | en |
dc.relation.page | 76 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-07-19 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 2.27 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。